Medication Description: Alveofakt (Alveofakt)
ALVEEFACT (Alveofakt) *.
Highly purified natural surfactant derived from light cattle.
Suspension for intratracheal instillation.
The drug is proposed for use in the syndrome of respiratory failure (distress syndrome) in newborns (premature), associated with a deficiency of surfactant.
The drug is administered by intratracheal instillation.
Enter during the first hour after birth in a dose of 1, 2 ml per 1 kg of body weight, then, if necessary, repeat the introduction of another 3 times in the following days - only 4 single doses.
Apply the drug in combination with artificial ventilation of the lungs and other necessary means and methods of therapy.
Alveofakt is a representative of a fundamentally new group of drugs that need in-depth study. Currently, the search and study of new similar tools.